articleLeukemiaMar 12, 2009Closed access

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

AHAndreas HochhausSGS G O'BrienFGFrançois GuilhotBDBrian DrukerSBSusan Branford

Heidelberg University · University Hospital Heidelberg · +8 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

844
total citations
FWCI
47.80
Percentile
100%
References
33
Citations per year

Authors

15

Topics & keywords

Topics
Keywords
  • Imatinib
  • Medicine
  • Imatinib mesylate
  • Myeloid leukemia
  • Internal medicine
  • Randomized controlled trial
  • Cytarabine
  • Oncology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.